Cytotoxicity mechanisms of plumbagin in drug-resistant tongue squamous cell carcinoma. (10th December 2020)

• Record Type: Journal Article
• Authors: Xue, Danfeng; Zhou, Xiongming; Qiu, Jiaxuan
• Is Part Of: Journal of pharmacy and pharmacology. Volume 73:Number 1(2021)
• Page Start: 98
• Page End: 109
• Publication Date: 2020-12-10
• Subjects: apoptosis -- plumbagin -- tongue squamous cell carcinoma -- drug resistance -- reactive oxygen species; Pharmacy -- Periodicals; Pharmacology -- Periodicals; 615.1
• DOI: 10.1093/jpp/rgaa027
• Languages: English
• ISSNs: 0022-3573

Abstract

Abstract: Objectives: To evaluate the inhibitory effect and mechanism of plumbagin (PLB) against drug-resistant tongue squamous cell carcinoma (TSCC), and whether its antitumour effect is not affected by tumour drug resistance. Methods: TSCC sensitive CAL27 cells and drug-resistant CAL27/RE cells were used to study the cytotoxicity and mechanism of PLB in vitro, including CCK-8 analysis, colony formation, DAPI staining, flow cytometry assay, transmission electron microscopy, western blotting assay, autophagy, apoptosis and ROS fluorescent probes. BALB/c nude mice xenograft models were used to study the growth inhibitory effect of PLB in vivo . Key findings: The results showed that the cell viability and proliferation inhibition and apoptosis induction abilities of PLB on drug-resistant cells were more obvious than that on sensitive cells. And PLB induced protective autophagy in TSCC cells. Mechanistically, PLB induced apoptosis and autophagy by generating reactive oxygen species to mediate JNK and AKT/mTOR pathways. Finally, the growth inhibitory effect of PLB against drug-resistant TSCC was also confirmed in vivo . Conclusions: PLB will be a promising anticancer agent to overcome drug-resistant TSCC without being affected by its drug resistance properties.